4.4 Article

Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents

Journal

CHEMISTRYOPEN
Volume 4, Issue 2, Pages 183-191

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/open.201402091

Keywords

antitumor; gold(III); mitochondrial permeability transition pore; pyrrolidinedithiocarbamates (PDT); reactive oxygen species (ROS)

Funding

  1. Progetti di Ateneo dell'Universita di Padova [CPDA123598]

Ask authors/readers for more resources

Transition metals offer many possibilities in developing potent chemotherapeutic agents. They are endowed with a variety of oxidation states, allowing for the selection of their coordination numbers and geometries via the choice of proper ligands, leading to the tuning of their final biological properties. We report here on the synthesis, physico-chemical characterization, and solution behavior of two gold(III) pyrrolidinedithiocarbamates (PDT), namely [(AuBr2)-Br-III(PDT)] and [(AuCl2)-Cl-III(PDT)]. We found that the bromide derivative was more effective than the chloride one in inducing cell death for several cancer cell lines. [(AuBr2)-Br-III(PDT)] elicited oxidative stress with effects on the permeability transition pore, a mitochondrial channel whose opening leads to cell death. More efficient antineoplastic strategies are required for the widespread burden that is cancer. In line with this, our results indicate that [(AuBr2)-Br-III(PDT)] is a promising antineoplastic agent that targets cellular components with crucial functions for the survival of tumor cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1

Carlos Sanchez-Martin, Daniela Menon, Elisabetta Moroni, Mariarosaria Ferraro, Ionica Masgras, Justin Elsey, Jack L. Arbiser, Giorgio Colombo, Andrea Rasola

Summary: The study uncovers HDCA as a potential TRAP1 selective inhibitor for use in antineoplastic therapy in tumor cells, by reversing TRAP1-dependent downregulation of SDH, reducing tumor cell proliferation rates, increasing mitochondrial superoxide levels, and abolishing tumorigenic growth.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Review Oncology

Filling the gap between risk assessment and molecular determinants of tumor onset

Federica Chiara, Stefano Indraccolo, Andrea Trevisan

Summary: Over the past two decades, studies have linked tumor onset to environmental exposure to carcinogens, shifting focus from solely mutational burden to a more complex understanding of the factors involved in tumor formation. Consequently, traditional risk assessment strategies based on the 'mutator model' require urgent updates in order to keep pace with advances in our understanding of cancer biology.

CARCINOGENESIS (2021)

Article Cell Biology

Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells

Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, Ionica Masgras, Andrea Rasola, Mauro Salvi, Lorenzo A. Pinna, Maria Ruzzene

Summary: CK2, an overexpressed Ser/Thr protein kinase in many cancers, plays a crucial role in the uncontrolled proliferation, motility, and survival of cancer cells. This study reveals that both CK2 alpha and alpha' isoforms contribute to cell proliferation, survival, and tumorigenicity, with a prominent role for CK2 alpha in tumor metabolism.

CELLS (2021)

Review Biochemistry & Molecular Biology

Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters

Francesco Ciscato, Lavinia Ferrone, Ionica Masgras, Claudio Laquatra, Andrea Rasola

Summary: Hexokinases, particularly Hexokinase 2 (HK2), play a critical role in glucose metabolism and are highly expressed in insulin-sensitive tissues and neoplastic cells. In addition to its enzymatic activity, HK2 can regulate autophagy and cell death, as well as intracellular Ca2+ fluxes, at the mitochondria-associated membranes (MAMs). Targeting HK2 subcellular localization in MAMs may offer a promising anti-tumor strategy by disrupting its functions in metabolic and survival pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Neurofibromin Deficiency and Extracellular Matrix Cooperate to Increase Transforming Potential through FAK-Dependent Signaling

Andrea Errico, Anna Stocco, Vincent M. Riccardi, Alberto Gambalunga, Franco Bassetto, Martina Grigatti, Amedeo Ferlosio, Gianluca Tadini, Debora Garozzo, Stefano Ferraresi, Andrea Trevisan, Sandra Giustini, Andrea Rasola, Federica Chiara

Summary: Neurofibromatosis type 1 is a genetic disease that predisposes to tumors of the nervous system, primarily neurofibroma. Research has shown that cell-cell cooperativity and the dynamics of the extracellular matrix play important roles in the progression of the disease, and treatment with MEK and FAK inhibitors has shown promise in abolishing the transforming ability of Pnf cells.

CANCERS (2021)

Article Multidisciplinary Sciences

Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase

Andrea Carrer, Ludovica Tommasin, Justina Sileikyte, Francesco Ciscato, Riccardo Filadi, Andrea Urbani, Michael Forte, Andrea Rasola, Ildiko Szabo, Michela Carraro, Paolo Bernardi

Summary: The nature of the mitochondrial permeability transition pore (PTP) remains debated, with the possibility that it can be mediated by F-ATP synthase or adenine nucleotide translocator. Through genetic modifications and cell experiments, researchers identified the essential role of certain mitochondrial subunits in turning the F-ATP synthase into the PTP, and showed that the ANT can contribute to channel formation in the absence of an assembled F-ATP synthase.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3

Ionica Masgras, Giuseppe Cannino, Francesco Ciscato, Carlos Sanchez-Martin, Fereshteh Babaei Darvishi, Francesca Scantamburlo, Marco Pizzi, Alessio Menga, Dolores Fregona, Alessandra Castegna, Andrea Rasola

Summary: The loss of neurofibromin leads to the growth of tumors and a rewiring of mitochondrial metabolism. This study found that the depletion of neurofibromin inhibits the expression and activity of NADH dehydrogenase, reducing respiration and intracellular NAD(+) levels in an ERK-dependent manner. However, the expression of alternative NADH dehydrogenase NDI1 increases the NAD(+)/NADH ratio and enhances the activity of the NAD(+)-dependent deacetylase SIRT3, impairing tumorigenicity in neurofibromin-deficient cells. Additionally, mimicking the antineoplastic effect of NDI1 can be achieved through the administration of NAD(+) precursors or increasing the expression of the NAD(+) deacetylase SIRT3, and this effect is synergistic with the depletion of the mitochondrial chaperone TRAP1 and its enhancement of succinate dehydrogenase activity.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation

Giuseppe Cannino, Andrea Urbani, Marco Gaspari, Mariaconcetta Varano, Alessandro Negro, Antonio Filippi, Francesco Ciscato, Ionica Masgras, Christoph Gerle, Elena Tibaldi, Anna Maria Brunati, Giorgio Colombo, Giovanna Lippe, Paolo Bernardi, Andrea Rasola

Summary: This study reveals that the mitochondrial chaperone TRAP1 interacts with F-ATP synthase, increasing its catalytic activity and counteracting the inhibitory effect of CyPD. Additionally, TRAP1 directly inhibits the channel activity of F-ATP synthase and reverses PTP induction by CyPD, thus preventing mitochondrial depolarization and cell death. These findings highlight the importance of TRAP1 in cell bioenergetics and survival.

CELL DEATH AND DIFFERENTIATION (2022)

Article Immunology

Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations

Marco Fonzo, Annamaria Nicolli, Stefano Maso, Lorenzo Carrer, Andrea Trevisan, Chiara Bertoncello

Summary: This study investigated the relationship between overweight/obesity and antibody persistence after vaccination against measles, mumps, rubella (MMR), and hepatitis B virus (HBV). The results showed that there was no significant association between lack of serologic protection and BMI for both HBV vaccine and each component of the MMR vaccine.

VACCINES (2022)

Article Immunology

Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination

Marco Fonzo, Chiara Bertoncello, Andrea Trevisan

Summary: This study aimed to assess long-term protection 10-20 years after primary HBV vaccination and investigate the effects of age at first dose, sex, and time between doses. The results showed that early vaccination had a better long-term protective effect, while the impact on vaccination in adolescence was not significant.

NPJ VACCINES (2022)

Article Immunology

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova

Paola Mason, Rosario Rizzuto, Luca Iannelli, Flavio Baccaglini, Valerio Rizzolo, Andrea Baraldo, Barbara Melloni, Francesca Maffione, Camilla Pezzoli, Maria Laura Chiozza, Giampietro Rupolo, Marco Biasioli, Filippo Liviero, Maria Luisa Scapellato, Andrea Trevisan, Stefano Merigliano, Alberto Scuttari, Angelo Moretto, Bruno Scarpa

Summary: This study investigated the adverse effects of two SARS-CoV-2 vaccines in a real-life preventive setting at the University of Padova in Italy. It was found that the ChAdOx1 nCoV-19 vaccine caused more adverse effects after the first dose, while the BNT162b2 vaccine caused more adverse effects after the second dose.

VACCINES (2023)

Letter Oncology

Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma

Damanti Carlotta Caterina, Ferrone Lavinia, Gaffo Enrico, Garbin Anna, Tosato Anna, Contarini Giorgia, Gallingani Ilaria, Angioni Roberta, Molon Barbara, Borile Giulia, Carraro Elisa, Pillon Marta, Scarmozzino Federico, Dei Tos Angelo Paolo, Pizzi Marco, Ciscato Francesco, Rasola Andrea, Biffi Alessandra, Bortoluzzi Stefania, Lovisa Federica, Mussolin Lara

CANCER COMMUNICATIONS (2023)

Article Biology

Analysis of the Effects of Hexokinase 2 Detachment From Mitochondria-Associated Membranes with the Highly Selective Peptide HK2pep

Francesco Ciscato, Federica Chiara, Riccardo Filadi, Andrea Rasola

Summary: The crucial role of HK2 in metabolic rewiring of tumors is well established, and a targeted peptide named HK2pep has been designed to detach HK2 and reduce tumor mass effectively.

BIO-PROTOCOL (2021)

No Data Available